173 related articles for article (PubMed ID: 20964987)
1. [(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].
Marquié Sayagués M; Da Silva Alves L; Molina-Porcel L; Alcolea Rodríguez D; Sala Matavera I; Sánchez-Saudinós MB; Camacho Martí V; Estorch Cabrera M; Blesa González R; Blesa González R; Gómez-Isla T; Gómez-Isla T; Lleó Bisa A; Lleó Bisa A
Neurologia; 2010 Sep; 25(7):414-21. PubMed ID: 20964987
[TBL] [Abstract][Full Text] [Related]
2. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
[TBL] [Abstract][Full Text] [Related]
3. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
4. Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
Novellino F; Bagnato A; Salsone M; Cascini GL; Nicoletti G; Arabia G; Pugliese P; Morelli M; Paglionico S; Cipullo S; Manna I; De Marco EV; Condino F; Chiriaco C; Morgante L; Zappia M; Quattrone A
Neurobiol Aging; 2010 Nov; 31(11):1903-11. PubMed ID: 19135762
[TBL] [Abstract][Full Text] [Related]
5.
Kane JPM; Roberts G; Petrides GS; Lloyd JJ; O'Brien JT; Thomas AJ
Parkinsonism Relat Disord; 2019 May; 62():79-84. PubMed ID: 30709778
[TBL] [Abstract][Full Text] [Related]
6. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
[TBL] [Abstract][Full Text] [Related]
8. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
Sakamoto F; Shiraishi S; Ogasawara K; Tsuda N; Nakagawa M; Tomiguchi S; Yamashita Y
Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068
[TBL] [Abstract][Full Text] [Related]
9. Autopsy Validation of the Diagnostic Accuracy of
Matsubara T; Kameyama M; Tanaka N; Sengoku R; Orita M; Furuta K; Iwata A; Arai T; Maruyama H; Saito Y; Murayama S
Neurology; 2022 Apr; 98(16):e1648-e1659. PubMed ID: 35256483
[TBL] [Abstract][Full Text] [Related]
10. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
11. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
12. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
13. (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
Kim JS; Park HE; Oh YS; Song IU; Yang DW; Park JW; Lee KS
J Neurol Sci; 2015 Oct; 357(1-2):173-7. PubMed ID: 26208800
[TBL] [Abstract][Full Text] [Related]
14. Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy.
Kobayashi K; Sumiya H; Nakano H; Akiyama N; Urata K; Koshino Y
Int J Geriatr Psychiatry; 2010 Jan; 25(1):55-65. PubMed ID: 19637401
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake.
Takenoshita S; Terada S; Oshima E; Yamaguchi M; Hayashi S; Hinotsu K; Esumi S; Shinya T; Yamada N
Psychogeriatrics; 2019 Nov; 19(6):566-573. PubMed ID: 30809892
[TBL] [Abstract][Full Text] [Related]
16. Potential diagnostic value of
Abbasi M; Ghalandari N; Farzanefar S; Aghamollaii V; Ahmadi M; Ganji M; Afarideh M; Loloee S; Naseri M; Tafakhori A
Clin Neurol Neurosurg; 2017 Dec; 163():163-166. PubMed ID: 29112909
[TBL] [Abstract][Full Text] [Related]
17. Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy.
Fujishiro H; Nakamura S; Kitazawa M; Sato K; Iseki E
J Neurol Sci; 2012 Apr; 315(1-2):115-9. PubMed ID: 22129938
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S
Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
Yoshita M; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakajima K; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Samuraki M; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamasaki J; Yamashina S; Yamada M
PLoS One; 2015; 10(3):e0120540. PubMed ID: 25793585
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
